Malignant neoplasm of duodenum
ICD-10 C17.0 is a billable code used to indicate a diagnosis of malignant neoplasm of duodenum.
Malignant neoplasm of the duodenum is a rare form of cancer that arises in the first section of the small intestine, known as the duodenum. This type of cancer can manifest as adenocarcinomas, neuroendocrine tumors, or lymphomas, with adenocarcinomas being the most common. Symptoms may include abdominal pain, weight loss, jaundice, and gastrointestinal bleeding. Due to its location, diagnosis can be challenging, often requiring imaging studies such as CT scans or MRIs, endoscopic evaluations, and biopsy for definitive diagnosis. The rarity of duodenal malignancies can lead to delays in diagnosis, as symptoms may be nonspecific and attributed to more common gastrointestinal disorders. Treatment typically involves surgical resection, chemotherapy, and radiation therapy, depending on the stage and type of cancer. Early detection is crucial for improving outcomes, but the subtlety of symptoms often complicates timely diagnosis.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of duodenal cancer, staging, and treatment response evaluation.
Ensure accurate coding of tumor type and stage; consider multidisciplinary notes.
Endoscopy reports, biopsy results, and clinical notes on symptoms.
Evaluation of gastrointestinal symptoms leading to suspicion of malignancy.
Document all findings thoroughly to support coding and billing.
Used when surgical intervention is required for duodenal cancer.
Operative reports detailing the procedure and findings.
Oncology and gastroenterology must coordinate documentation.
Common symptoms include abdominal pain, weight loss, jaundice, and gastrointestinal bleeding. However, symptoms can be nonspecific and may resemble other gastrointestinal disorders.
Diagnosis typically involves imaging studies such as CT scans or MRIs, endoscopic evaluations, and biopsy for histological confirmation.
Treatment often includes surgical resection of the tumor, chemotherapy, and radiation therapy, depending on the type and stage of cancer.